首页> 外文期刊>生物医学研究杂志(英文版) >Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte
【24h】

Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte

机译:分流,通道和脂蛋白内体运输:肝细胞胆固醇稳态的新模型

获取原文
获取原文并翻译 | 示例
       

摘要

The liver directs cholesterol metabolism in the organism.All the major fluxes of cholesterol within the body involve the liver:dietary cholesterol is directed to the liver;cholesterol from peripheral cells goes to the liver;the liver is a major site of cholesterol synthesis for the organism;cholesterol is secreted from the liver within the bile,within apoB lipoproteins and translocated to nascent HDL.The conventional model of cholesterol homeostasis posits that cholesterol from any source enters a common,rapidly exchangeable pool within the cell,which is in equilibrium with a regulatory pool.Increased influx of cholesterol leads rapidly to decreased synthesis of cholesterol.This model was developed based onin vitro studies in the fibroblast and validated only for LDL particles.The challenges the liver must meet in vivo to achieve cholesterol homeostasis are far more complex.Our model posits that the cholesterol derived from three different lipoproteins endosomes has three different fates:LDL-derived cholesterol is largely recycled within VLDL with most of the cholesterol shunted through the hepatocyte without entering the exchangeable pool of cholesterol;high density lipoprotein-derived CE is tmnscytosed into bile;and chylomicron remnant-derived cholesterol primarily enters the regulatory pool within the hepatocyte.These endosomal channels represent distinct physiological pathways and hepatic homeostasis represents the net result of the outcomes of these distinct channels.Our model takes into account the distinct physiological challenges the hepatocyte must meet,underlie the pathophysiology of many of the apoB dyslipoproteinemias and account for the sustained effectiveness of therapeutic agents such as statins.
机译:肝脏指导着生物体内的胆固醇代谢。体内所有主要的胆固醇通量都与肝脏有关:饮食中的胆固醇直接进入肝脏;外围细胞中的胆固醇进入肝脏;肝脏是肝脏中胆固醇合成的主要场所。胆固醇是从胆汁中的肝脏分泌出来的,载于apoB脂蛋白中,并转移到新生的HDL中。传统的胆固醇稳态模型认为,任何来源的胆固醇都会进入细胞内一个常见的,可快速交换的池中,并与一个胆固醇流入增加迅速导致胆固醇合成减少,该模型是基于成纤维细胞的体外研究开发的,仅针对LDL颗粒进行了验证。肝脏体内达到胆固醇稳态所必须面对的挑战要复杂得多。我们的模型假设来自三种不同脂蛋白内体的胆固醇具有三种不同脂肪es:LDL衍生的胆固醇在VLDL中大量循环利用,大部分胆固醇通过肝细胞分流而未进入可交换的胆固醇库;高密度脂蛋白衍生的CE被胆汁细胞化;乳糜微粒残留的胆固醇主要进入监管池这些内体通道代表不同的生理途径,肝稳态代表这些不同通道的结果的净结果。我们的模型考虑了肝细胞必须满足的独特生理挑战,这是许多apoB脂蛋白血症和解释了他汀类药物等治疗药物的持续有效性。

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2017年第2期|95-107|共13页
  • 作者单位

    Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada;

    Department of Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada;

    Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada;

    Department of Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 糖尿病;
  • 关键词

  • 入库时间 2022-08-19 03:47:48
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号